CRBP
CRBP
NASDAQ · Biotechnology

Corbus Pharmaceuticals Holdi

$2.75
-0.27 (-8.80%)
As of Nov 19, 1:25 PM ET ·
CRBP vs Biotechnology Average
Profit Margin
CRBP -3.5%
Avg -192.1%
Rev Growth
CRBP +4.2%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
CRBP Corbus Pharmaceuticals Holdi $2.75 -8.80% 71.30M — -3.5% +4.2% — Current
ABBV Abbvie Inc $283.54 -0.86% 520.47B 50.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $438.82 -1.14% 252.64B 26.9 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $166.53 -1.45% 208.95B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $520.66 -2.94% 134.82B 33.9 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $923.34 -2.35% 98.38B 20.4 31.4% +5.6% — Buy Compare
MRNA Moderna Inc $199.33 +1.29% 90.54B — -145.2% -53.4% — Hold Compare
NTRA Natera Inc $289.92 +0.15% 45.90B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $159.43 -0.24% 37.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $247.13 -1.70% 37.21B 107.1 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $38.96 +0.59% 28.64B — -3,629.2% -48.7% — Strong buy Compare
INSM Insmed Inc $144.46 +20.58% 25.90B — -210.5% +35.2% — Strong buy Compare
INCY Incyte Corp $115.87 -1.64% 24.53B 60.8 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $559.10 -3.16% 24.15B 19.6 41.9% +18.0% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $147.82 -1.06% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $156.59 -3.85% 16.90B 24.1 16.7% +24.3% — Strong buy Compare
EXEL Exelixis Inc $65.83 -3.60% 16.88B 19.1 33.7% +12.9% — Hold Compare
BBIO Bridgebio Pharma Inc $78.18 +0.22% 15.27B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $93.04 -2.88% 11.48B 27.8 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $10.57 +0.67% 11.32B — 15.4% -3.6% — Buy Compare